19757-97-2 Usage
Description
Methyl 2-hydroxy-2-methoxyacetate, also known as Methyl 2-(hydroxymethyl)-2-methoxyacetate, is an organic compound with the molecular formula C4H8O4. It is a colorless liquid with a sweet taste and is soluble in water. Methyl 2-hydroxy-2-methoxyacetate is characterized by its ester and ether functional groups, which contribute to its reactivity and versatility in various chemical reactions.
Uses
Used in Pharmaceutical Synthesis:
Methyl 2-hydroxy-2-methoxyacetate is used as a chemical reagent for the preparation of pharmaceutical compounds, specifically in the synthesis of Bryostatin 1 derivatives. These derivatives act as potent inhibitors of protein kinase C (PKC) isoforms, which play a crucial role in various cellular processes, including cell growth, differentiation, and apoptosis. By targeting PKC-1, these derivatives have the potential to be effective in cancer therapy, particularly in the treatment of solid tumors.
In the pharmaceutical industry, Methyl 2-hydroxy-2-methoxyacetate is used as a key intermediate in the synthesis of various drug candidates, owing to its unique chemical properties and reactivity. Its ability to form esters and ethers makes it a valuable building block for the development of novel therapeutic agents with potential applications in the treatment of various diseases, including cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 19757-97-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,7,5 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 19757-97:
(7*1)+(6*9)+(5*7)+(4*5)+(3*7)+(2*9)+(1*7)=162
162 % 10 = 2
So 19757-97-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H8O4/c1-7-3(5)4(6)8-2/h3,5H,1-2H3
19757-97-2Relevant articles and documents
Quinoline compound as well as preparation method, pharmaceutical composition and application thereof
-
Paragraph 0369-0372, (2021/03/05)
The invention discloses a compound shown as a general formula I, pharmaceutically acceptable salt or metabolite of the compound, and a preparation method, a pharmaceutical composition and applicationof the compound. The compound shown in the general formula I, the pharmaceutically acceptable salt thereof or the metabolite thereof has a good treatment effect on virus infection, has small toxic andside effects, and can be used for preventing or treating virus infection.
CROSSLINKING AGENT, CROSSLINKED POLYMER, AND USES THEREOF
-
Page/Page column 20, (2010/08/22)
There is provided a novel crosslinking agent for use in crosslinked polymer fabrication, specifically a crosslinking agent containing at least one compound selected from glyoxylate and a glyoxylic acid ester derivative represented by the following general formula (1): wherein R1 and R2 each independently represents an alkyl group having 1 to 10 carbon atoms and R3 represents a hydrogen atom or an alkyl group having 1 to 10 carbon atoms.
Imidazole based solid-supported catalysts for the benzoin condensation
Storey, John M.D.,Williamson, Craig
, p. 7337 - 7339 (2007/10/03)
New polymer-supported imidazolium salts have been synthesised, and their utility as pre-catalysts in the benzoin reaction has been demonstrated.
